Published in FEBS Lett on March 24, 2000
Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol (2001) 6.05
Gcn4p, a master regulator of gene expression, is controlled at multiple levels by diverse signals of starvation and stress. Eukaryot Cell (2002) 3.21
TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell (2004) 2.61
Efflux-mediated antifungal drug resistance. Clin Microbiol Rev (2009) 2.44
Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J Infect Dis (2011) 2.17
Unfolding of the C-terminal domain of the J-protein Zuo1 releases autoinhibition and activates Pdr1-dependent transcription. J Mol Biol (2012) 2.04
Chemical inhibition of the Pho85 cyclin-dependent kinase reveals a role in the environmental stress response. Proc Natl Acad Sci U S A (2001) 1.87
Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Antimicrob Agents Chemother (2004) 1.86
Dissection of transient oxidative stress response in Saccharomyces cerevisiae by using DNA microarrays. Mol Biol Cell (2002) 1.81
Population genomics of drug resistance in Candida albicans. Proc Natl Acad Sci U S A (2002) 1.76
Leucine biosynthesis in fungi: entering metabolism through the back door. Microbiol Mol Biol Rev (2003) 1.66
Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics (2003) 1.57
Impact of nonsense-mediated mRNA decay on the global expression profile of budding yeast. PLoS Genet (2006) 1.55
A novel design of whole-genome microarray probes for Saccharomyces cerevisiae which minimizes cross-hybridization. BMC Genomics (2003) 1.51
Effect of 21 different nitrogen sources on global gene expression in the yeast Saccharomyces cerevisiae. Mol Cell Biol (2007) 1.50
Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother (2003) 1.49
A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5. Proc Natl Acad Sci U S A (2008) 1.48
Oxidative stress-activated zinc cluster protein Stb5 has dual activator/repressor functions required for pentose phosphate pathway regulation and NADPH production. Mol Cell Biol (2006) 1.46
An evolutionary and functional assessment of regulatory network motifs. Genome Biol (2005) 1.45
Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction. Nature (2016) 1.43
Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae. Eukaryot Cell (2007) 1.35
War1p, a novel transcription factor controlling weak acid stress response in yeast. Mol Cell Biol (2003) 1.23
A genomic approach to gene fusion technology. Proc Natl Acad Sci U S A (2001) 1.22
Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother (2011) 1.21
An artificial transcription activator mimics the genome-wide properties of the yeast Pdr1 transcription factor. EMBO Rep (2001) 1.21
New insights into the pleiotropic drug resistance network from genome-wide characterization of the YRR1 transcription factor regulation system. Mol Cell Biol (2002) 1.20
Multidrug resistance in fungi. Eukaryot Cell (2007) 1.20
Transcription factor control of growth rate dependent genes in Saccharomyces cerevisiae: a three factor design. BMC Genomics (2008) 1.19
Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob Agents Chemother (2002) 1.18
Early expression of yeast genes affected by chemical stress. Mol Cell Biol (2005) 1.13
Structure and properties of transcriptional networks driving selenite stress response in yeasts. BMC Genomics (2008) 1.07
Cross talk between sphingolipids and glycerophospholipids in the establishment of plasma membrane asymmetry. Mol Biol Cell (2004) 1.06
Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob Agents Chemother (2010) 1.06
Membrane-active compounds activate the transcription factors Pdr1 and Pdr3 connecting pleiotropic drug resistance and membrane lipid homeostasis in saccharomyces cerevisiae. Mol Biol Cell (2007) 0.99
Multidrug resistance in fungi: regulation of transporter-encoding gene expression. Front Physiol (2014) 0.98
Responses of pathogenic and nonpathogenic yeast species to steroids reveal the functioning and evolution of multidrug resistance transcriptional networks. Eukaryot Cell (2007) 0.97
Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi. Biochim Biophys Acta (2008) 0.97
Differential regulation of ceramide synthase components LAC1 and LAG1 in Saccharomyces cerevisiae. Eukaryot Cell (2004) 0.96
Proteomic analysis of azole resistance in Candida albicans clinical isolates. Antimicrob Agents Chemother (2004) 0.95
Saccharomyces cerevisiae Aqr1 is an internal-membrane transporter involved in excretion of amino acids. Eukaryot Cell (2004) 0.95
Compensatory activation of the multidrug transporters Pdr5p, Snq2p, and Yor1p by Pdr1p in Saccharomyces cerevisiae. FEBS Lett (2008) 0.93
Combined phylogeny and neighborhood analysis of the evolution of the ABC transporters conferring multiple drug resistance in hemiascomycete yeasts. BMC Genomics (2009) 0.91
Progress in the application of DNA microarrays. Environ Health Perspect (2001) 0.90
Antagonism between two mechanisms of antifungal drug resistance. Eukaryot Cell (2006) 0.89
Pdr3 is required for DNA damage induction of MAG1 and DDI1 via a bi-directional promoter element. Nucleic Acids Res (2004) 0.87
Overproduction of PDR3 suppresses mitochondrial import defects associated with a TOM70 null mutation by increasing the expression of TOM72 in Saccharomyces cerevisiae. Mol Cell Biol (2001) 0.85
Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquine. Malar J (2003) 0.83
Involvement of vacuolar sequestration and active transport in tolerance of Saccharomyces cerevisiae to hop iso-alpha-acids. Appl Environ Microbiol (2009) 0.82
Discovery of a modified transcription factor endowing yeasts with organic-solvent tolerance and reconstruction of an organic-solvent-tolerant Saccharomyces cerevisiae strain. Appl Environ Microbiol (2008) 0.82
Activation of signaling pathways related to cell wall integrity and multidrug resistance by organic solvent in Saccharomyces cerevisiae. Curr Genet (2013) 0.82
Functional linkage between genes that regulate osmotic stress responses and multidrug resistance transporters: challenges and opportunities for antibiotic discovery. Antimicrob Agents Chemother (2013) 0.81
Ssz1 restores endoplasmic reticulum-associated protein degradation in cells expressing defective cdc48-ufd1-npl4 complex by upregulating cdc48. Genetics (2009) 0.81
Gene expression and evolution of antifungal drug resistance. Antimicrob Agents Chemother (2009) 0.81
Activity of the Kluyveromyces lactis Pdr5 multidrug transporter is modulated by the Sit4 protein phosphatase. J Bacteriol (2001) 0.80
Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors. Mol Pharmacol (2008) 0.80
Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells. Antimicrob Agents Chemother (2014) 0.79
ELM1 is required for multidrug resistance in Saccharomyces cerevisiae. Genetics (2006) 0.78
Control of Plasma Membrane Permeability by ABC Transporters. Eukaryot Cell (2015) 0.77
Microarrays, antiobesity and the liver. Ann Hepatol (2005) 0.77
Reduced Glucose Sensation Can Increase the Fitness of Saccharomyces cerevisiae Lacking Mitochondrial DNA. PLoS One (2016) 0.75
The CRIT framework for identifying cross patterns in systems biology and application to chemogenomics. Genome Biol (2011) 0.75
Current awareness on comparative and functional genomics. Yeast (2000) 0.75
High-Copy Overexpression Screening Reveals PDR5 as the Main Doxorubicin Resistance Gene in Yeast. PLoS One (2015) 0.75
Identification of Genes in Saccharomyces cerevisiae that Are Haploinsufficient for Overcoming Amino Acid Starvation. G3 (Bethesda) (2017) 0.75
Tuning the Sensitivity of the PDR5 Promoter-Based Detection of Diclofenac in Yeast Biosensors. Sensors (Basel) (2017) 0.75
Isolation, heterological cloning and sequencing of the RPL28 gene in Kluyveromyces lactis. Curr Genet (2002) 0.75
Life with 6000 genes. Science (1996) 41.51
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
The composite genome of the legume symbiont Sinorhizobium meliloti. Science (2001) 9.11
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol (1999) 4.64
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Sequence of introns and flanking exons in wild-type and box3 mutants of cytochrome b reveals an interlaced splicing protein coded by an intron. Cell (1980) 4.26
The proton-translocating ATPase of the fungal plasma membrane. Biochim Biophys Acta (1981) 4.15
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet (1995) 3.85
Complete DNA sequence of yeast chromosome XI. Nature (1994) 3.51
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Site-specific DNA endonuclease and RNA maturase activities of two homologous intron-encoded proteins from yeast mitochondria. Cell (1989) 2.93
PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem (1994) 2.92
Analysis of the chromosome sequence of the legume symbiont Sinorhizobium meliloti strain 1021. Proc Natl Acad Sci U S A (2001) 2.83
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Critical sequences within mitochondrial introns: pleiotropic mRNA maturase and cis-dominant signals of the box intron controlling reductase and oxidase. Cell (1982) 2.63
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
An essential yeast gene encoding a homolog of ubiquitin-activating enzyme. J Biol Chem (1995) 2.50
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p. J Biol Chem (1998) 2.39
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Mobile introns: definition of terms and recommended nomenclature. Gene (1989) 2.26
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Complete inventory of the yeast ABC proteins. Nat Genet (1997) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Complete nucleotide sequence of Saccharomyces cerevisiae chromosome X. EMBO J (1996) 2.06
Supervised harvesting of expression trees. Genome Biol (2001) 2.02
The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J Biol Chem (1987) 2.02
Antibiotic efflux pumps. Biochem Pharmacol (2000) 1.99
Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae. J Biol Chem (1990) 1.98
Unified inventory of established and putative transporters encoded within the complete genome of Saccharomyces cerevisiae. FEBS Lett (1998) 1.98
Complete DNA sequence of yeast chromosome II. EMBO J (1994) 1.97
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Molecular cloning of a family of plant genes encoding a protein homologous to plasma membrane H+-translocating ATPases. Biochem Biophys Res Commun (1989) 1.96
The yeast H+-ATPase gene is controlled by the promoter binding factor TUF. J Biol Chem (1989) 1.94
Characterization of a histone-like protein extracted from yeast mitochondria. Proc Natl Acad Sci U S A (1979) 1.93
The nucleotide sequence of Saccharomyces cerevisiae chromosome IV. Nature (1997) 1.92
The nucleotide sequence of Saccharomyces cerevisiae chromosome XII. Nature (1997) 1.89
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther (1991) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. BMJ (2000) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta (1994) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Typing prion isoforms. Nature (1997) 1.82
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
A mitochondrial RNA maturase gene transferred to the yeast nucleus can control mitochondrial mRNA splicing. Cell (1986) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J Biol Chem (1996) 1.79
Classification of all putative permeases and other membrane plurispanners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae. FEMS Microbiol Rev (1997) 1.77
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Kofi Annan describes new health fund for developing countries. BMJ (2001) 1.76
Ionophore toxicity in turkey breeders. Avian Dis (1983) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J Mol Microbiol Biotechnol (2001) 1.72
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology (1994) 1.70
Improvement of stiff-man syndrome with vigabatrin. Neurology (1997) 1.68
Cancer registries fear imminent collapse. BMJ (2000) 1.68
A pseudogene structure in 5S DNA of Xenopus laevis. Cell (1977) 1.67
In yeast, the 3' untranslated region or the presequence of ATM1 is required for the exclusive localization of its mRNA to the vicinity of mitochondria. Mol Cell Biol (2000) 1.67
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67
Single base substitution in an intron of oxidase gene compensates splicing defects of the cytochrome b gene. Nature (1982) 1.65
Illusory perceptions of space and time preserve cross-saccadic perceptual continuity. Nature (2001) 1.64
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol Gen Genet (1994) 1.63
Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes. Mol Gen Genet (1997) 1.63